Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus

Transplantation

Volumn 65, Issue 7, 1998, Pages 899-905

  Wang, Mou Er ^a   Tejpal, Neelam ^a   Qu, Xumei ^a   Yu, Jiang ^a   Okamoto, Masahiko ^a   Stepkowski, Stanislaw M ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FINGOLIMOD; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT;

EID: 0032522702     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199804150-00007     Document Type: Article

References (22)

1. Adachi K, Kohara T, Nakano K, et al. Design, synthesis, and structure-activity relationship of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem 1995; 5: 853.
2. Fujita T, Inoue K, Yamamoto S, et al. Fungal metabolites: a potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot 1994; 47: 208.
3. Suzuki S, Enosawa S, Kakefuda T, et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996; 61: 200.
4. Li X-K, Shinomiya T, Enosawa S, Kakefuda T, Amemiya H, Suzuki S. Induction of lymphocyte apoptosis by a novel immunosuppressant, FTY720: relation with Fas, Bcl-2, and Bax expression. Transplant Proc 1997; 29: 1267.
5. Li X-K, Enosawa S, Kakefuda T, Amemiya H, Suzuki S. FTY720, a novel immunosuppressive agent, enhances upregulation of the cell adhesion molecule ICAM-1 in TNF-α-treated human umbilical vein endothelial cells. Transplant Proc 1997; 29: 1265.
6. Chiba K, Hoshino Y, Suzuki C, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc 1996; 28: 1056.
7. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Transplant Proc 1996; 28: 1060.
8. Suzuki S, Ensenowa S, Kakefuda T, Amemiya H, Hoshino Y, Chiba K. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720. Transplant Proc 1996; 28: 1375.
9. Masubuchi Y, Kawaguchi T, Ohtsuki M, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats. Transplant Proc 1996; 28: 1064.
10. Kawaguchi T, Hoshino Y, Rahman F, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Transplant Proc 1996; 28: 1062.
11. Stepkowski SM, Napoli KL, Wang M-E, Qu X, Chou T-C, Kahan BD. The effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats. Transplantation 1996; 62: 986.
12. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 517: 225.
13. Kamada N, Calne RY. Orthotopic liver transplantation in the rat: technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47.
14. Moncik GJ, Russell PS. Transplantation of small bowel in the rat: technique and immunological considerations. Surgery 1971; 70: 693.
15. Rideout DC, Chou T-C. Introduction. In: Chou T-C, Rideout DC, eds. Synergism, antagonism, and potentiation in chemotherapy. San Diego: Academic Press, 1991: 3.
16. Tu Y, Stepkowski SM, Chou TC, Kahan BD. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice. Transplantation 1995; 59: 177.
17. Kahan BD, Gibbons S, Tejpal N, Stepkowski SM, Chou T-C. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation 1991; 51: 232.
18. Kahan BD. Sirolimus: a new agent for clinical renal transplantation. Transplant Proc 1997; 29: 48.
19. Calne R, White DJ, Third S, et al. Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet 1987; 2: 1223.
20. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725.
21. Dunn J, Golden D, Van Buren CT, Lewis RM, Lawen J, Kahan BD. Causes of graft loss beyond two years in the cyclosporine era. Transplantation 1990; 49: 349.
22. Murgia MG, Jordan S, Kahan BD. The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisolone-treated renal transplant patients. Kidney Int 1996; 49: 209.